Blackstone Inc’s SpringWorks Therapeutics SWTX Stock Holding History

Blackstone Inc’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,835	Closed	-$791K	–	276
2025 Q2	$791K	Buy	+16,835	New	+$749K	﹤0.01%	130
2024 Q1	–	Sell	-75,000	Closed	-$2.74M	–	191
2023 Q4	$2.74M	Buy	+75,000	New	+$1.96M	0.01%	96

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Blackstone Inc's SWTX Position: Q3 2025 in Review

Blackstone Inc sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 16,835 shares — an estimated $791K sold.

Blackstone Inc first reported a position in SWTX in Q4 2023 and held it in 2 quarters. The position peaked at $2.74M in Q4 2023. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Blackstone Inc reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Blackstone Inc sold 16,835 SpringWorks Therapeutics shares in Q3 2025, an estimated $791K.
Blackstone Inc first reported a position in SpringWorks Therapeutics in Q4 2023 and held it in 2 quarters.
Blackstone Inc's SpringWorks Therapeutics position peaked at $2.74M in Q4 2023.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Blackstone Inc's 13F filing for Q3 2025, filed 14 Nov 2025.